2-BETA-HYDROXY-ANDROST-4-ENE-3,17-DIONE
Compound with spectra: 1 NMR, and 1 MS (GC)
| SpectraBase Compound ID | 1WURnxMXX81 |
|---|---|
| InChI | InChI=1S/C19H26O3/c1-18-8-7-14-12(13(18)5-6-17(18)22)4-3-11-9-15(20)16(21)10-19(11,14)2/h9,12-14,16,21H,3-8,10H2,1-2H3/t12-,13-,14-,16-,18-,19-/m0/s1 |
| InChIKey | TUUUEQXMRRIGLT-HDOZPKFNSA-N |
| Mol Weight | 302.41 g/mol |
| Molecular Formula | C19H26O3 |
| Exact Mass | 302.188195 g/mol |
| Enantiomer InChIKey | TUUUEQXMRRIGLT-PWEFDDCVSA-N |
| Copyright | Copyright © 2011-2024 Wiley-VCH GmbH. All Rights Reserved. |
|---|---|
| Source of Spectrum | Dr. Makin, London Hospital Medical College, UK |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CD3OD |
- ANDROST-4-ENE-2.BETA.-OL-3,17-DIONE
- (2S,8R,9S,10R,13S,14S)-2-hydroxy-10,13-dimethyl-7,8,9,10,11,12,13,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17(2H,6H)-dione
- 2-HYDROXYANDROST-4-ENE-3,17-DIONE
ANDROST-4-ENE-2-BETA,17-BETA-DIOL-3-ONE
3-ALPHA-UREIDO-ANDROST-4-EN-17-ONE
(8R,9S,10S,13S,14S)-10-(azidomethyl)-13-methyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-dione
Androst-4-ene-3,17-dione, 18-hydroxy-
(2R,8S,9S,10R,13R,14S,17S)-17-ethyl-2,10,13-trimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
10-BETA-HYDROXY-19-NOR-ANDROST-4-ENE-3,17-DIONE
Androst-4-ene-3,17-dione, 19-(propylthio)-
Androst-4-ene-3,17-dione, 19-(2-propynylthio)-
Androst-4-ene-3,17-dione, 19-(methylthio)-
Androst-4-ene-3,17-dione, 19-bromo-
| Title | Journal or Book | Year |
|---|---|---|
| Structure and stereochemistry of products of hydroxylation of human steroid hormones by a housefly cytochrome P450 (CYP6A1) | Magnetic Resonance in Chemistry | 2006 |
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.